Literature DB >> 29973125

Bone Toolbox: Biomarkers, Imaging Tools, Biomechanics, and Histomorphometry.

Aurore Varela1, Jacquelin Jolette1.   

Abstract

Bone is a unique tissue with turnover, metabolic, and cellular activities that vary through development to aging and with a mineralized matrix in which the current state and the history of a bone coexist. Qualitative histopathology often lacks sensitivity to detect changes in bone formation, mineralization and resorption, which often requires chronic dosing to result in structural changes such as variation in bone mass and geometry. A large panel of modalities can be used to fully analyze the health of the skeleton, including biomarker evaluation in serum or urine, imaging techniques ranging from radiology to computed tomography, biomechanical testing, and undecalcified tissue processing with bone histomorphometry. The use of clinically relevant biomarkers provides an important noninvasive, sensitive, rapid, and real-time tool to monitor bone activity at the whole skeleton level when conducting safety assessments in a preclinical setting. Imaging modalities also allow in vivo longitudinal assessments with a powerful, noninvasive and clinically translatable tools to monitor drug effects. Different imaging modalities are used in the preclinical studies to evaluate the bone tissues: standard radiography, dual-energy X-ray absorptiometry, peripheral quantitative computed tomography (pQCT), micro-computed tomography, and high-resolution pQCT. Bone histomorphometry is an important tool that provides sensitive evaluation to detect effects of test articles on bone resorption, formation, mineralization, remodeling rates and growth to address a potential target- or class-related theoretical bone liability. Ultimately, the measurement of bone mechanical properties in pharmaceutical testing is critical to understand the potential effects of that pharmaceutical on bone health and fracture risk. Important considerations are required for including these different techniques in toxicology rodents and nonrodent studies, to actually integrate these into safety assessment.

Entities:  

Keywords:  DXA; HR-pQCT; biomechanics; bone biomarkers; histomorphometry; micro-CT; osteodensitometry; pQCT; skeleton

Mesh:

Substances:

Year:  2018        PMID: 29973125     DOI: 10.1177/0192623318779565

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  5 in total

Review 1.  Mechanical stimuli-mediated modulation of bone cell function-implications for bone remodeling and angiogenesis.

Authors:  Wenqing Liang; Xudong Wu; Yongqiang Dong; Xuerong Chen; Ping Zhou; Fangming Xu
Journal:  Cell Tissue Res       Date:  2021-10-19       Impact factor: 5.249

2.  [An optimized method for embedding undecalcified mouse tibias in plastic blocks].

Authors:  Zhonghao Deng; Jingde Lin; Zheting Liao; Yufan Chen; Desheng Wu; Shuhao Feng; Nachun Chen; Baohong Zhao; Liang Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-09-30

3.  A 12-month prospective exploratory study of muscle and fat characteristics in individuals with mild-to-moderate hip osteoarthritis.

Authors:  Aderson Loureiro; Maria Constantinou; Belinda Beck; Rod S Barrett; Laura E Diamond
Journal:  BMC Musculoskelet Disord       Date:  2019-06-14       Impact factor: 2.362

4.  Clinical Performance of Short Expandable Dental Implants for Oral Rehabilitation in Highly Atrophic Alveolar Bone: 3-year Results of a Prospective Single-Center Cohort Study.

Authors:  Waldemar Reich; Ramona Schweyen; Jeremias Hey; Sven Otto; Alexander Walter Eckert
Journal:  Medicina (Kaunas)       Date:  2020-07-03       Impact factor: 2.430

Review 5.  Current Status of the Diagnosis and Management of Osteoporosis.

Authors:  Agustín Aibar-Almazán; Ana Voltes-Martínez; Yolanda Castellote-Caballero; Diego Fernando Afanador-Restrepo; María Del Carmen Carcelén-Fraile; Elena López-Ruiz
Journal:  Int J Mol Sci       Date:  2022-08-21       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.